J Goldman & Company LP Has Boosted Its Intra Cellular Therapies (ITCI) Stake; 2 Analysts Are Bullish Coca-Cola FEMSA, S.A.B. de C.V. (KOF) Last Week

January 13, 2018 - By Louis Casey

Among 7 analysts covering Coca-Cola FEMSA (NYSE:KOF), 2 have Buy rating, 1 Sell and 4 Hold. Therefore 29% are positive. Coca-Cola FEMSA had 18 analyst reports since July 24, 2015 according to SRatingsIntel. The firm earned “Overweight” rating on Monday, March 7 by Barclays Capital. The stock of Coca-Cola FEMSA, S.A.B. de C.V. (NYSE:KOF) earned “Neutral” rating by JP Morgan on Friday, June 3. Citigroup upgraded Coca-Cola FEMSA, S.A.B. de C.V. (NYSE:KOF) on Wednesday, September 14 to “Neutral” rating. Credit Suisse downgraded the shares of KOF in report on Friday, November 17 to “Neutral” rating. The firm has “Reduce” rating given on Monday, January 11 by Nomura. The stock has “Overweight” rating by JP Morgan on Friday, May 12. The rating was downgraded by Goldman Sachs on Friday, January 15 to “Neutral”. Goldman Sachs downgraded Coca-Cola FEMSA, S.A.B. de C.V. (NYSE:KOF) on Monday, January 18 to “Neutral” rating. The firm has “Hold” rating by Santander given on Friday, September 11. The firm has “Overweight” rating by Barclays Capital given on Friday, October 14. See Coca-Cola FEMSA, S.A.B. de C.V. (NYSE:KOF) latest ratings:

17/11/2017 Broker: Credit Suisse Old Rating: Outperform New Rating: Neutral Downgrade

J Goldman & Company Lp increased Intra Cellular Therapies Inc (ITCI) stake by 31.71% reported in 2017Q3 SEC filing. J Goldman & Company Lp acquired 26,700 shares as Intra Cellular Therapies Inc (ITCI)’s stock declined 19.44%. The J Goldman & Company Lp holds 110,900 shares with $1.75M value, up from 84,200 last quarter. Intra Cellular Therapies Inc now has $1.03B valuation. The stock increased 2.55% or $0.47 during the last trading session, reaching $18.87. About 435,257 shares traded. Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) has declined 68.76% since January 13, 2017 and is downtrending. It has underperformed by 85.46% the S&P500.

The stock increased 1.16% or $0.82 during the last trading session, reaching $71.66. About 69,791 shares traded. Coca-Cola FEMSA, S.A.B. de C.V. (NYSE:KOF) has declined 2.10% since January 13, 2017 and is downtrending. It has underperformed by 18.80% the S&P500.

Coca-Cola FEMSA, S.A.B. de C.V., a franchise bottler, produces, markets, distributes, and sells Coca-Cola trademark beverages. The company has market cap of $15.05 billion. The firm offers a portfolio of products, including sparkling beverages, still beverages, juices, sports, and energy drinks, as well as teas, waters, isotonics, and dairy products. It has a 20.89 P/E ratio. It provides a portfolio of approximately 154 brands directly, as well as through retail outlets and restaurants to clients in Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil, and Argentina.

Investors sentiment increased to 2.77 in 2017 Q3. Its up 1.91, from 0.86 in 2017Q2. It increased, as 9 investors sold ITCI shares while 21 reduced holdings. 45 funds opened positions while 38 raised stakes. 39.74 million shares or 30.25% more from 30.51 million shares in 2017Q2 were reported. 242,156 are owned by C Ww Wide Grp A S. New York-based Alliancebernstein Ltd Partnership has invested 0% in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI). Hillhouse Capital Mgmt Limited stated it has 0.26% in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI). Samlyn Capital Limited Liability invested 0.3% of its portfolio in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI). Stifel Corporation has 14,850 shares for 0% of their portfolio. Bnp Paribas Arbitrage Sa owns 4,196 shares. Tiaa Cref Investment Mngmt Ltd Liability Corporation invested in 0% or 108,156 shares. Morgan Stanley accumulated 583,646 shares. Goldman Sachs Group Inc Inc owns 0% invested in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) for 227,624 shares. Voya Mngmt Limited Liability Corporation invested in 0% or 16,911 shares. 110,900 were accumulated by J Goldman And Ltd Partnership. Moreover, Blackrock has 0% invested in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI). Rock Springs Management Limited Partnership reported 0.14% of its portfolio in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI). Endurance Wealth Management has invested 0% in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI). Renaissance Ltd Llc stated it has 401,600 shares or 0.01% of all its holdings.

J Goldman & Company Lp decreased Match Group Inc stake by 157,368 shares to 33,932 valued at $787,000 in 2017Q3. It also reduced Kapstone Paper & Packaging C (NYSE:KS) stake by 26,420 shares and now owns 93,580 shares. American Eagle Outfitters Ne (Call) (NYSE:AEO) was reduced too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>